ERBB2 and cancer: This IDC was grade 1, ER positive, progesterone receptor-positive and Her2/neu-negative cancer without lymphovascular invasion (Figures 1, 2), treated with mastectomy and axillary dissection, followed by adjuvant locoregional radiotherapy (50.4 Gy in 28 fractions) and hormonal therapy (anastrozole) for 10 years. Mean follow-up duration was 53.8 months (range: 6–175 months).